Search
RBB_Partnering_Interests-2018-12.pdf
Respiratory_Partnering_Interests_2018-12.pdf
Technologies_Partnering_Interests-2018-12.pdf
Partnering in Technologies HP SEPT 2024 CORP_0.pdf
Partnering in Technologies AH MAY 2024 CORP.pdf
Partnering in Oncology & Cancer Imm HP OCTOBER 2024 CORP.pdf
Partnering in Retinal Health HP OCTOBER 2024 CORP_1.pdf
Partnering in RBB HP OCTOBER CORP.pdf
Partnering in Biotherapeutics HP OCTOBER 2024 CORP_1.pdf
Partnering in Technologies HP OCTOBER 2024 CORP.pdf
Partnering in Mental Health Disorders HP OCTOBER 2024 CORP.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
Partnering with Boehringer Ingelheim HP OCTOBER 2024 CORP.pdf
Partnering in Immunology & Resp HP OCTOBER 2024 CORP.pdf
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Therapeutics
Therapeutics
Purchasing
Purchasing at Boehringer Ingelheim
Research Collaborations
Research Collaborations
Clinical Collaborations
Clinical Collaborations
New partnership to develop schizophrenia treatments
Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments
Henke-Sass Wolf develop needle free device
Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs
Survey with Ipsos to gain insights human-animal bond
Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.
Our Health and Safety initiative - BE SAFE
Health and safety are of great importance to Boehringer Ingelheim.
Animal Health Innovation
Animal Health Innovation